Graphique 1 - Faculté de Médecine et de Pharmacie de Fès

66 - Flynn MK, Webster GD, Amundsen CL.
The effect of botulinum-A toxin on patients with severe urge urinary incontinence.
J Urol 2004;172:2316–20
67 - L. Peyrat
Une injection détrusorienne de toxine botulique
Pelv Perineol (2006) 1: NS22
68 - Schulte-Baukloh H, Michael T, Schobert J, Stolze T, Knispel H.
Efficacy of botulinum-A toxin in children with detrusor hyperreflexia due to
myelomeningocele: preliminary results.
Urology 2002;59:325–8.
69 - Reitz A, Stöhrer M, Kramer G, Del Popolo G, Chartier-Kastler E, Pannek J, et al.
European experience of 200 cases treated with botulinum-A toxin injections into the
detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.
Eur Urol 2004;45:510–5.
70 - Schurch B, de Seze M, Denys P, Chartier-Kastler E, Ismael S, Haab F, et al.
Botulinum toxin A (Botox®) in neurogenic urinary incontinence: results from a
multicentre randomised, controlled trial.
Neurolo Urodyn 2004;23: 609–10.
71 - Grosse JO, Kramer AE, Löchner-Ernest D, Stöher M.
Success of repeat detrusor injections of botulinum A toxin in patients with severe
neurogenic detrusor overactivity and incontinence.
Eur Urol 2003;2(suppl):141.
72 - Schmid DM, Schuch B, John H, Hauri D.
Botulinum toxin injections to treat overactive bladder [abstract 516].
Eur Urol [suppl] 2004;3:131.
73 - Rapp DE, Lucioni A, Katz EE, O’Connor RC, Gerber GS, Bales GT.
Use of botulinum-A toxin for the treatment of refractory overactive bladder
symptoms: an initial experience.
Urology 2004;63:1071–5.
97